Relmada Therapeutics : NDV-01 AUA 2026 Poster
Relmada Therapeutics Inc RLMD
$7.04
▼ -2.36%
($-0.17)
Open
$7.26
Prev Close
$7.21
Day Range
$7.01 – $7.50
52W Range
$0.49 – $8.00
Market Cap
$738.43M
Beta
0.40
EPS (TTM)
$-1.15
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2014-03-03 |
| Shares Out. | 104,890,000 |
| Website | relmada.com/ ↗ |
| Phone | 16468763459 |
Relmada Therapeutics Inc is a publicly traded company under the ticker symbol RLMD on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
11 analysts (2026-05-01)
📰 Latest News for RLMD
Relmada Therapeutics Files For Mixed Shelf Offering, Size Not Disclosed
Relmada Therapeutics, Inc. (RLMD) Q1 2026 Earnings Call Transcript
Transcript : Relmada Therapeutics, Inc., Q1 2026 Earnings Call, May 12, 2026
Transcript: Relmada Therapeutics Q1 2026 Earnings Conference Call
Relmada Therapeutics Q1 EPS $(0.22) Misses $(0.20) Estimate
Earnings Scheduled For May 12, 2026